SEC Form 4 · accession 0001100682-26-000111
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Director
Period of report
Jun 29, 2026
Accepted (ET)
Jul 1, 2026 · 4:59 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 29, 2026 | S | 75,000 | $225.00 | D | 31,596 | D | |
| Common Stock | holding | — | — | — | 10,780 | I | 2025 GRAT | |
| Common Stock | holding | — | — | — | 20,000 | I | 2026 GRAT | |
| Common Stock | holding | — | — | — | 155,611 | I | By Trust | |
| Common Stock | holding | — | — | — | 10,000 | I | By Trust Held By Spouse | |
| Common Stock | holding | — | — | — | 5,423 | I | 2024 GRAT |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was adopted by the reporting person on March 6, 2026.